The University of NC at Chapel Hill, Clinical and Translational Research Center (CTRC) is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
The University of NC at Chapel Hill, Clinical and Translational Research Center (CTRC) has participated in 2 clinical trials.
Therapeutic areas: Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Primary Sclerosing Cholangitis.
Sponsors: Pfizer, Gilead Sciences.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of NC at Chapel Hill, Clinical and Translational Research Center (CTRC) has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of NC at Chapel Hill, Clinical and Translational Research Center (CTRC) has 2 clinical trials on record. Their work covers Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Primary Sclerosing Cholangitis.
The University of NC at Chapel Hill, Clinical and Translational Research Center (CTRC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.